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Abstract
Background: Changes and relationships of components of the cytokine and IGF systems have
been shown in placenta and cord serum of fetal growth restricted (FGR) compared with normal
newborns (AGA). This study aimed to analyse a data set of clinical and biochemical data in FGR and
AGA newborns to assess if a mathematical model existed and was capable of identifying these two
different conditions in order to identify the variables which had a mathematically consistent
biological relevance to fetal growth.
Methods: Whole villous tissue was collected at birth from FGR (N = 20) and AGA neonates (N
= 28). Total RNA was extracted, reverse transcribed and then real-time quantitative (TaqMan) RT-
PCR was performed to quantify cDNA for IGF-I, IGF-II, IGFBP-1, IGFBP-2 and IL-6. The
corresponding proteins with TNF-α in addition were assayed in placental lysates using specific kits.
The data were analysed using Artificial Neural Networks (supervised networks), and principal
component analysis and connectivity map.
Results: The IGF system and IL-6 allowed to predict FGR in approximately 92% of the cases and
AGA in 85% of the cases with a low number of errors. IGF-II, IGFBP-2, and IL-6 content in the
placental lysates were the most important factors connected with FGR. The condition of being FGR
was connected mainly with the IGF-II placental content, and the latter with IL-6 and IGFBP-2
concentrations in placental lysates.
Conclusion:  These results suggest that further research in humans should focus on these
biochemical data. Furthermore, this study offered a critical revision of previous studies. The
understanding of this system biology is relevant to the development of future therapeutical
interventions possibly aiming at reducing IL-6 and IGFBP-2 concentrations preserving IGF
bioactivity in both placenta and fetus.
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Background
Most cases of fetal growth restriction (FGR) are still of
unknown origin (1). The interest in FGR has grown
because approximately 13% of these subjects do not
present a catch-up growth (2), and in recent years, the
concept of a "Fetal Origin of Adult Disease" has been
introduced to describe modifications in utero that might
influence adult patho-physiology (3).
The IGF system is recognized to be crucial for fetal growth,
as experiments in knockout mice have shown [4-7]. It is
well known that IGF-I and IGF-II are both synthesised in
the placenta [8-10]. IGFBP-1, IGFBP-2, IGFBP-4 and
IGFBP-6 are expressed by all placenta cell types while
IGFBP-3 and IGFBP-5 are expressed only by some [11].
We have recently shown that IGF-I, IGFBP-2 and IGF-II
gene expression was increased in the placentas and that
cord serum IGFBP-1 and IGFBP-2 were also increased in
FGR [12].
Cytokines are thought to play an important role in regu-
lating placenta development and growth although they
are poorly studied. The placenta produces the pro-inflam-
matory cytokine IL-6, and TNF-α [13,14] and human
decidua cells, in vitro, secrete IL-6 [15]. Very few fetal data
have been published. Blood cultures stimulated with
Lipopolysaccharide S, show an increase in placental IL-6,
IL-1β, and TNF-α [16]. Recently, IL-6 gene expression and
protein content in the placenta have been found signifi-
cantly increased in FGR newborns and to be positively
related with IGFBP-1 and IGFBP-2 gene expressions[12],
confirming cytokine and IGF system relationships as pre-
viously described [17-20].
However, all above data are observational and conclu-
sions come from traditional statistical analysis. In recent
years a new array of technical tools and techniques has
developed which has allowed a better understanding of
biological networks. These advances have indicated that
most networks in social, technological and biologic sys-
tems have common designs that are governed by simple
and quantifiable organizing principles and that networks
pervade all aspects of human health. Soon these advances
will affect medical practice and a "network medicine" will
develop [21].
The method used by Artificial Neural Networks (ANNS)
aims to understand natural processes and recreate those
processes using automatic models. These networks deter-
mine a noteworthy improvement, compared with tradi-
tional methods of analysis, and allow a method of
forecasting with better and safer understanding of the
relationships between variables, in particular non-linear
relationships [22]. ANNs function by initially learning a
known set of data from a given problem with a known
solution (training) and then the networks, inspired by the
analytical processes of the human brain, are able to recon-
struct the imprecise rules which may be underlying a com-
plex set of data (testing). In recent years ANNs have been
used successfully in medicine [23-29], and have been
applied to solve clinical problems in pediatrics including
those related to preterm births [30-34]. Common algo-
rithms of linear projections of variables as the Principal
Component Analysis do not require any specific distribu-
tion of data. However, a limitation of these methods is
that if the relationships between variables are non linear,
it is not able to preserve, with adequate accuracy, the geo-
metrical structure of the original space. Moreover, map-
ping is generally based on a specific kind of "distance"
among variables and gives origin to a "static" projection of
possible associations losing the intrinsic dynamics due to
active interactions of variables in living systems of real
world [35]. These limitations have been recently over-
come using a new paradigm of variables mapping which
creates a sort of semantic connectivity and has been
described by Buscema and Grossi [35].
Using this latter method and supervised ANNS, we aimed
to analyse a known set of clinical and biochemical data in
FGR and normal newborns to establish if a mathematical
model existed and was capable of identifying conditions
of FGR and appropriateness for gestational age, identify-
ing the variables, among those analysed, which had a
mathematically consistent biological relevance to fetal
growth, and their relationships. We showed that in partic-
ular, IGF-II, IGFBP-2 and IL-6 concentrations in placental




Twenty FGR and 28 appropriate for gestational age (AGA)
births were followed. AGA births were defined on the
basis of a normal birth weight (< 80th and > 10th centile)
with respect to the Italian standards of referral [36] a nor-
mal pregnancy and the absence of maternal risk factors.
All pregnancies were dated correctly by ultrasound during
the first trimester of gestation. The FGR pregnancies were
diagnosed by ultrasound according to the following crite-
ria: abdominal circumference < 10th centile and shift of
fetal growth with a reduction of abdominal circumference
with respect to the measure taken within the 20th week of
gestation. The diagnosis of FGR was made within the
32nd week of gestation and was ascribed to a probable
placental cause after excluding other causes as infections,
chromosomal abnormalities, genetic syndromes, mater-
nal malnutrition, substance abuse, gross placental abnor-
malities and multiple fetuses.BMC Pediatrics 2008, 8:24 http://www.biomedcentral.com/1471-2431/8/24
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No cases with increased blood pressure, gestational diabe-
tes or reduced amount of amniotic fluid were included in
the study. All neonates, both FGR and AGA, were deliv-
ered by elective caesarean section (CS) to avoid confound-
ing factors in placental assays. The indications for CS in
the AGA newborns were: intra-hepatic colestasis in a
woman who had undergone a previous CS; premature
rupture of membranes with breech presentation and
delivery within 4 hr with no signs of infection; refusal of
vaginal delivery for psychological reasons; and elective CS
because of a previous CS.
At birth we collected the following information: maternal
age, weight at birth of both parents, body mass index
(BMI) of the mother before pregnancy and at delivery,
previous gynaecological history, medical history during
pregnancy, fetal biophysical data (exact duration of preg-
nancy, growth trend, fetal and maternal doppler veloci-
metry data in FGR, Non Stress Test), clinical data at
delivery (indication for CS, neonatal sex, weight, length,
head circumference, Apgar score, acid-base equilibrium,
and perinatal data), and weight and macroscopic appear-
ance of the placenta.
The main clinical data are reported in Table 1.
Collection of biological material
In all cases, four fragments of perifunicular villous tissue
of approximately 5 mm3 were taken close to the fetal
plate, rinsed repeatedly in sterile saline solution at 0°C.
Storage conditions were standardized as previously
described [12].
Isolation of RNA
RNA extraction was performed as previously described
[12].
cDNA synthesis
Complementary DNA (cDNA) was synthesized using 1 μg
of total RNA sample according to the recommendations
of the manufacturer (Applied Biosystems, Foster City, Cal-
ifornia), and as previously described [12].
TaqMan Assay on Demand Gene Expression
Applied Biosystems TaqMan Assay-on-Demand Gene
Expression pre-designed primers and probes were used.
To normalise for variables in gene expression, two control
housekeeping genes were used, Ubiquitin (Assay ID:
Hs00261902-m1) and 18S ribosomal RNA (Assay ID:
Hs99999901-s1) [37]. IGF-I (Assay ID: Hs00153126-
m1), IGF-II (Assay ID: Hs00171254-m1), IGFBP-1 (Assay
ID: Hs00426258-m1), IGFBP-2 (Assay ID: Hs00167151-
m1) and IL-6 (Assay ID: Hs00174131-m1) primers were
used according to the manufacturer's instructions. Special
attention was paid to selecting genes belonging to differ-
ent functional classes, which significantly reduced the
chance that genes might be co-regulated. Real-Time Quan-
titative RT-PCR was performed on a TaqMan ABI 7700
Sequence Detector System (Applied Biosystems) as previ-
ously described [12,37].
Total protein content
The lysates were extracted as previously described [12].
The total protein content was expressed in μg per mg of
placenta.
Protein assays
Total IGF-I, IGF-II, IGFBP-2 and IL-6 were measured as
previously described [12]. TNF-α was assayed using an
ultrasensitive ELISA method ((Biosource International
Camarillo, CA, USA), The sensitivity of the method was <
0.09 pg/ml, the intra- and inter-assay coefficients of varia-
tion were 6.7 and 7.7%, respectively.
Database
We aimed to re-analyze from a completely new perspec-
tive most of the data, with TNF-α in addition, we obtained
from our previous study, comparing FGR and AGA new-
borns [12]. Sixteen variables were selected for the analysis
from the entire database for 48 subjects. The indexes of
linear correlation among these variables were very low
(data not shown).
Clinical, medical history and biochemical data were
administered to the ANNS (Table 2). The models we used
aimed at correct classification of the subjects in two
Table 1: Main features at birth of fetal growth restricted and appropriate for gestational age newborns
FGR AGA
Males/Females 9M/11F 15M/13F
Gestational age (weeks) 33.4 ± 0.8* 36.7 ± 0.5
Weight of Placenta (gr) 349.8 ± 35.3 * 615.9 ± 27.9
Weight at birth (Kg) 1.5 ± 0.1 * 2.9 ± 0.1
Length at birth (cm) 41.1 ± 1.3 * 49.7 ± 0.6
Head circumference at birth (cm) 29.4 ± 0.8 * 34.2 ± 0.4
FGR: fetal growth restricted; AGA: appropriate for gestational age: * p < 0.05 versus AGABMC Pediatrics 2008, 8:24 http://www.biomedcentral.com/1471-2431/8/24
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classes: 1) FGR (fetal growth restriction), 2) AGA (appro-
priate for gestational age).
ANNs analysis
The ANNs model implemented to process the data in our
study belonged to the Supervised networks in which the
result of the processing (the desired output) is already
defined. Supervised ANNs calculate an error function
measuring the distance between the desired fixed output
(target) and their own output, and adjust the connection
strengths during the training process to minimize the
result of the error function. Several models of supervised
ANNs have been used, differentiated by topology and
having their functioning dynamics managed by particular
learning laws. In addition to the Back-Propagation net-
work (BP), a typical Feed-Forward network trained with
the Error Back-Propagation learning rule (or Delta Rule)
(38), the Sine Net and BiModal learning laws were used
[39,40].
The Sine Net (SN) is a family of multi-layer ANNs with a
different unit activation function with respect to the BP. In
the SN the input signal is non-linearly transformed
through a non-monotonic sinusoidal function. A specific
frequency and wave length in the sinusoidal function con-
strain the global input configuration and the connection
weights, allowing a qualitative assessment of the output.
The SN has excellent convergence and extrapolation
capacities even on complex datasets.
The Bi-Modal networks (BM) are multi-layered networks
that differ from BP and SN because all the hidden nodes
are realized by 2 sub-nodes, each equipped with its own
input connections: the first sub-node operates according
to the descending gradient technique, the second through
vectorial quantification. The outputs of the two nodes
were then composed in a single output value. The Bi-
Modal demonstrated an excellent convergence capacity
on complex problems.
Research protocols
The database was analyzed using two different research
protocols: Random and Optimized.
In the Random Protocol [41], the global database was ran-
domly split in two independent sub-samples. The two sets
of independent sub-samples obtained were used, first as a
training and testing set during the ANNs learning process
and then were exchanged during the validation phase.
The Optimized Protocol also subdivided the entire data-
base in two subsets of data but, in this case, the splitting
was "optimized" by a data pre-processing able to extract
training and testing (T&T) samples in which the case dis-
tribution represented the global structure of the database.
The optimization procedure enhanced the reliability of
the network model.
T&T was a system that performs an optimization of train-
ing and testing sub-samples through the iteration of data-
splitting procedures on the global database. In the T&T
system, based on the evolutionary algorithm GenD [42],
the optimization algorithm distributed the original sam-
ple into two or more sub-samples with the aim of obtain-
ing the maximum performance possible from an ANN
model trained on the first sample and validated on the
Table 2: List of variables analysed using Artificial Neural Networks (ANNS) and their linear correlation index (r2) with each target 
variable.
Variables Correlation index (r2)
1 Chronological age of the mother at delivery (years) 0,11
2 Sex of the newborn 0
3 Gestational age (weeks) 0,22
4 Other siblings (yes or No) 0,001
5 Number of other siblings 0,005
6 Number of previous abortions 0,000
7 Total placental protein content in lysates (mg/ml) 0,007
8 IGF-II concentration in placental lysates (ng/mg) 0,16
9 IGFBP-2 concentration in placental lysates (ng/mg) 0,05
10 IL-6 concentration in placental lysates (pg/mg) 0,09
11 TNF-α concentration in placental lysates (ng/mg) 0,05
12 IGF-I relative gene expression in placenta (A.U./18S, UBQ) 0,01
13 IGF-II relative gene expression in placenta (A.U./18S, UBQ) 0,02
14 IGFBP-1 relative gene expression in placenta (A.U./18S, UBQ) 0,05
15 IGFBP-2 relative gene expression in placenta (A.U./18S, UBQ) 0,08
16 IL-6 relative gene expression in placenta (A.U./18S, UBQ) 0,16
Biochemical data were measured as specified in materials and methods. Gene expressions are in arbitrary units (AU) with respect to two house-
keeping genes, 18 S ribosomal RNA (18S) and ubiquitin (UBQ). Specific protein concentrations in placental lysates are ng or pg per mg of placenta.BMC Pediatrics 2008, 8:24 http://www.biomedcentral.com/1471-2431/8/24
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second. The T&T system was supported by the Input Selec-
tion (IS) [42] system, a variable selection technique based
on the evolutionary algorithm GenD. When the database
was built, the data were collected including all variables
that may have had a correlation with the event being stud-
ied. The result of this approach was that a series of varia-
bles which did not contain information regarding the
process being examined were present. These variables,
inserted into the model, caused an increase of noise and a
greater difficulty for the ANN to learn the data correctly.
The IS system operated on a population of ANNs, each of
them extracting a different pool of independent variables
from a fixed dataset. Through the GenD evolutionary
algorithm, the different selections of variable, generated
by each ANN, may change over time, generation after gen-
eration. When the evolutionary algorithm no longer
improves, the process stops, and the best selection of
input variables is chosen and employed on the testing
subset. The evolutionary algorithm searched for the mini-
mal number of input variables that provided the best test-
ing performance of the ANN model.
Principal component analysis and connectivity map
A new mapping method was used to find out connectivity
traces among variables, using a mathematical approach
based on an artificial adaptive system, to define the
strength of the associations of each variable with all the
others in any dataset (the Auto Contractive Map-AutoCM
algorithm- Copyright Semeion Research Centre). After the
training phase, the weights matrix of the AutoCM repre-
sents the warped landscape of the dataset. Subsequently,
a simple filter to the weights matrix of the AutoCM system
was applied to obtain a map of the main connections
between the variables of the dataset and the basic seman-
tic of their similarities, defined connectivity map as
detailed in the paper by Buscema and Grossi [35].
Ethical approval
Informed consent was obtained from the mothers as
appropriate. The study was approved by the local Ethics
Committee (University of Parma Medical School).
Results
Random protocol
The first analysis, using the random protocol, yielded
results obtained by the FeedForward architecture based on
three learning laws: Back Propagation (BP), SineNet (SN),
BiModal (BM). The input vectors for the ANNs contained
16 variables. The two target conditions, FGR and AGA
(controls), were distinguished, approximately in 75% and
85% of the cases, respectively, with few mistakes (Table
3). The BP and the SN ANN models had similar perform-
ances and predicted FGR or AGA with the greatest accu-
racy.
Optimized protocol
In the optimized protocol the global database was proc-
essed twice by the IS system, reversing the two T&T sub-
sets. From the initial 16 variables the IS system selected 7
variables the first time and 9 variables the second time
(Table 4). The results of this analysis are summarized in
Table 5. Also in this case the BP and SN ANNs gave the
greatest accuracy and least errors in predicting FGR and
AGA. In general, the ANNs performances were enhanced
when processing the variables selected by IS instead of all
the variables of the database; the optimized procedure
allowed to predict FGR in approximately 92% of the cases
and AGA in 85% of the cases with a low number of errors.
Principal component analysis, and connectivity map
The first and second principal components analysis are
shown in Figure 1a. Different clusters of variables
emerged (first cluster: FGR, IL-6, IGF-II and IGFBP-2 con-
centrations in placental lysates, and IGF-II mRNA; second
cluster: total protein content in placental lysates, IGFBP-1,
IGFBP-2 and IL-6 mRNAs; third cluster: IGF-I mRNA,
newborn gender, number of abortions, mothers age at
Table 3: Random Protocol – Summary of results obtained by the Bi-modal (Bm), Back propagation (Bp) and Sine net (Sn) ANN 
models.
ANN Model Target Mean Accuracy % Errors
FGR (%) AGA (%) Arithmetic Weighted
BM 75,00 84.62 79,81 80,00 5
BP 75,00 84.62 79,81 80,00 5
SN 75,00 76,92 75,96 76,00 6
The percentage rates of correct classification of FGR and AGA are shown in the testing phase, together with the arithmetic and weighted mean 
accuracy.
FGR: fetal growth restriction;
AGA: appropriate for gestational age.
BM Bimodal neural network
BP: Back propagation neural network
SN: Sine net neural networkBMC Pediatrics 2008, 8:24 http://www.biomedcentral.com/1471-2431/8/24
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delivery; fourth cluster: gestational age, number and other
siblings, TNF-α concentration in placental lysates and
appropriateness for gestational ages). The third and fourth
principal components gave clusters which were partially
in contrast with the previous due to the limitations of the
traditional PCA analysis (Figure 1b). However, the new
algorithm provided a connectivity map which clarified the
existent relationships at a higher level of analysis as repre-
sented in Figure 2.
IGF-II concentration in placental lysates resulted to be the
principal hub of the system, i.e. the dominant variable.
This variable was most tightly connected with the condi-
tion of being FGR at birth, with IGFBP-2 and IL-6 concen-
trations in placental lysates, IGF-II mRNA, and total
placental protein concentration. This latter was related
with placental mRNA for IGFBP-1, IGFBP-2 and IL-6. The
concentration of IGFBP-2 in placental lysates was related
with the number of spontaneous abortions.
Another close relationship was detected among the
mother's age at delivery, gestational age and IGF-I mRNA
in the placenta. There was also a relationship of the
mother's age at delivery with the number of siblings. Ges-
tational age was related with TNF-α concentration in pla-
cental lysates, with appropriateness for gestational age
and newborn gender.
Discussion
This study explored the association between the IGF and
cytokine systems and fetal growth with complementary
non-linear approaches: supervised neural networks
(ANNS), and the semantic connectivity map.
Through ANNs, we established a consistent possibility to
predict fetal growth status on the basis of selected varia-
bles with a low average error rate (8–15%). This meant
that those variables contained specific information on the
occurrence of FGR. In particular, IGF-II, IGFBP-2 and IL-6
Table 4: Input variables selected by the optimized (I.S.) system.
Variables IS 1° selection IS 2° selection
Chronological age of the mother at delivery X X
Sex of the newborn
Gestational age XX
Other siblings XX
Number of other siblings
Number of previous abortions
Total placental protein content in lysates
IGF-II concentration in placental lysates X X
IGFBP-2 concentration in placental lysates X X
IL-6 concentration in placental lysates
TNF-α concentration in placental lysates
IGF-I relative gene expression in placenta X X
IGF-II relative gene expression in placenta X
IGFBP-1 relative gene expression in placenta
IGFBP-2 relative gene expression in placenta X X
IL-6 relative gene expression in placenta X
Table 5: Optimized Protocol – Summary of results obtained by each ANN model on the variables of the first (7 variables) and second 
(9 variables) selection using the IS system.
ANN Model Target Mean Accuracy % Errors
FGR (%) AGA (%) Arithmetic Weighted
BM 7 VAR. 91,67 84,62 88,14 88,00 3
BM 9 VAR. 91,67 76,92 84,29 84,00 4
BP 7 VAR. 91,67 84,62 88,14 88,00 3
BP 9 VAR. 91,67 84,62 88,14 88,00 3
SN 7 VAR. 75,00 92,31 83,65 84,00 4
SN 9 VAR. 75,00 84,62 79,81 80,00 5
FGR: fetal growth restriction;
AGA: appropriate for gestational age.
BM Bimodal neural network
BP: Back propagation neural network
SN: Sine net neural networkBMC Pediatrics 2008, 8:24 http://www.biomedcentral.com/1471-2431/8/24
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concentrations in placental lysates were the most impor-
tant determinants of fetal growth.
Through the connectivity map we established that IGF-II
concentration in placental lysates was directly connected
with the condition of FGR besides IL-6 and IGFBP-2 con-
centrations in lysates, and its corresponding mRNA.
A possible limit of the ANNS analysis is linked to the rel-
atively small sample size and to the subsequent unbal-
anced ratio between variables and records. In this
connection, however, adaptive learning algorithms of
inference, based on the principle of a functional approxi-
mation as artificial neural networks, overcame the prob-
lem of dimensionality. The internal validation of the
prediction accuracy is one of the most important prob-
lems in neural networks analysis. In fact, due to the restric-
tion of training procedures to just a part of the data set,
generally fifty percent, potential loss of power to recog-
nize hidden patterns emerges.
A difficult problem was to establish the size and quality of
the T&T sets because the complete data set was too small
or too complex to be divided into two subsets on the basis
of a pseudo-random criterion. However, the random divi-
sion of a data set into two or three subsets was logical as
we hypothesized that a simple function represented the
data set in an optimal way. In this study the issue of opti-
mization of the training and testing procedure was
addressed with the use of the evolutionary 'T&T' algo-
rithm, which ensured that the two halves of the data set
contained the same amount of relevant information.
Thus, the best division of the whole data set into a T&T set
was reached after a finite number of generations.
The other major challenge in neural networks analysis on
relatively small sample numbers in relation to a high
number of variables, was the selection of the more predic-
tive independent variables in order to reduce the so called
"white noise" which would have limited the generaliza-
tion capability of trained neural networks with respect to
new records. In this study the issue of variables selection
was addressed with the use of an evolutionary algorithm
called IS system, which allowed the best approximation in
a sustainable time of a typical non-polynomial hard prob-
lem which would have required an almost infinite com-
putational time.
The principal component analysis has limits as shown by
the different mapping obtained in the first and second
versus the third and fourth component analysis. The use
of Auto-CM, a new mapping system, overcomes these lim-
its preserving non linear relationships, showing explicit
connection schemes, capturing the complex dynamics of
Mapping of the first (left) and second (right) component analysis Figure 1
Mapping of the first (left) and second (right) component analysis. Four main clusters of variables emerged as 
described in results.BMC Pediatrics 2008, 8:24 http://www.biomedcentral.com/1471-2431/8/24
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adaptive interactions and creates a "semantic connectivity
map"[35].
Considering individual findings the connectivity map
showed a relationship of total placental protein content
with mRNA for different proteins which is easily
explained as the amount of protein is dependent on the
amount of mRNA translated into protein (relative gene
expression). Previously, we had shown that there was no
difference in the total amount of protein in the placenta
of FGR and AGA newborns, which was confirmed [12].
The IGF-II peptide is recognized as an important determi-
nant of fetal growth from animal [5] and human studies
[8,10]. In placentas from FGR newborns, IGF-II is
increased reflecting a possible protective mechanism to
promote growth in unfavourable conditions [12]. The
results of these analyses confirmed a major role of IGF-II
Connectivity map clarifying the clusters of variables, and single relationships among variables Figure 2
Connectivity map clarifying the clusters of variables, and single relationships among variables. 
Mother_Age_Delivery: Chronological age of the mother at delivery (years); newborn_gender: Sex of the newborn; 
Gestational_age: Gestational age (weeks); Other_siblings: Other siblings (yes or No); N_siblings: Number of other siblings; 
N_abortion: Number of previous abortions; Pla_total_pro: Total placental protein content in lysates (mg/ml); PLA_IGF2: IGF-II 
concentration in placental lysates (ng/mg); PLA_BP2: IGFBP-2 concentration in placental lysates (ng/mg); PLA_IL6: IL-6 concen-
tration in placental lysates (pg/mg); PL_TNF: TNF- concentration in placental lysates (ng/mg); mRNA_IGF1:IGF-I relative gene 
expression in placenta (A.U./18S, UBQ); mRNA_IGF2:IGF-II relative gene expression in placenta (A.U./18S, UBQ); mRna_BP1: 
IGFBP-1 relative gene expression in placenta (A.U./18S, UBQ); mRNA_BP2:IGFBP-2 relative gene expression in placenta (A.U./
18S, UBQ); mRNA_IL6:IL-6 relative gene expression in placenta (A.U./18S, UBQ); Controls: newborns appropriate for gesta-
tional age; IUGR: Intra uterine growth retardation (FGR fetal growth restricted).BMC Pediatrics 2008, 8:24 http://www.biomedcentral.com/1471-2431/8/24
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for fetal growth. The connectivity map evidenced a direct
relationship of IGF-II concentration in placental lysates
and the condition of FGR, and suggested an effect of IL-6
and IGFBP-2 concentrations in the placenta on IGF-II.
That IGF-II concentration in lysates was related with its
corresponding mRNA was not surprising and confirms
that one is looking at true biological effects.
This study did not confirm a major role for IGFBP-1 at var-
iance with published experimental data [43,44]. We pre-
viously identified the lesser phosphorylated isoforms of
IGFBP-1 to be the most increased in FGR; this finding sug-
gested a protective mechanism in FGR which would be in
line with the increased IGF-II concentrations observed in
placental lysates [12]. This could explain the results of this
study as only total IGFBP-1 concentration in the placenta
was analysed which may not be the relevant factor.
IGFBP-2 concentration in placental lysates resulted to be
an important variable in determining fetal growth. We
previously described increased IGFBP-2 gene expression
and peptide concentrations in the placenta in growth
restricted fetuses, suggesting that IGF bioactivity might be
significantly blunted in this condition [12]. The connec-
tivity map did not show a direct relationship of IGFBP-2
with FGR suggesting an indirect effect possibly consisting
in the regulation of IGF-II bioactivity.
The connection of IGFBP-2 concentration in lysates with
the number of spontaneous abortions strengthens further
the biological importance of this peptide in placenta for
fetal growth, although we do not have an explanation for
this.
IGFBP-2 has been poorly studied to date, and has not
been considered previously an important bio-regulator of
IGF bio-availability [11].
IL-6 has been studied only recently and very few data are
available [13-15]. We showed that IL-6 mRNA was signif-
icantly increased in the placenta of FGR neonates [12].
The results of this analysis confirmed an important role
for IL-6.
In contrast to IL-6, a significant role of TNF-α was not
identified. Data in the literature in FGR are contrasting.
Some studies report unchanged TNF-α mRNA expression
in human placenta in FGR compared with controls [45]
whereas others report increased TNF-α in the perfusate of
FGR placentas [46]. TNF-α was increased in the serum and
in the amniotic fluid of mothers with fetuses suffering of
FGR [46,47]. We cannot exclude an indirect effect of TNF-
α through the regulation of other yet unknown factors,
however the connectivity map showed a connection only
with gestational age. Gestational age was connected with
appropriateness for gestational age also, possibly confirm-
ing that the more correct the duration of gestation the
greater the possibility that a fetus is appropriate.
Finally, the connectivity map showed that the mothers age
at delivery was connected with IGF-II concentration in
lysates and IGF-I mRNA, possibly suggesting that mater-
nal age is related with fetal growth. That maternal age is
related with the number of siblings is a rule of human
biology.
Conclusion
These analyses identified the importance of the biochem-
ical variables, IL-6, IGF-II and IGFBP-2 protein concentra-
tions in placental lysates, and offered a new insight into
placental markers of fetal growth within the IGF and
cytokine systems, confirmed they had relationships and
offered a critical assessment of studies performed to date.
It remains to be elucidated whether the factors identified
at the placental site are part of a pathological process or in
connection with regulatory mechanisms induced by dis-
turbances in the placenta resulting from previous patho-
logical changes. The data provided useful information for
the directions of future research, and the overall evidence
suggested that further research in humans should focus on
these biochemical data, at variance with the studies which
have focused mainly on IGF-I and IGFBP-1.
The understanding of this system biology is relevant to the
development of future therapeutical interventions possi-
bly aiming at reducing IL-6 and IGFBP-2 concentrations
preserving IGF bioactivity in both placenta and fetus.
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